Skip to main content

Table 3 Comparison of MPO, NT-proBNP, and NLR levels between the two groups

From: Clinical value of NT-proBNP, MPO, and NLR combined with echocardiography in prediction of malignant arrhythmia in elderly patients with valvular heart disease

 

VHD group (n = 50)

Healthy control group (n = 55)

P

MPO (mg/L)

123.10 ± 39.76

86.59 ± 20.62

 < 0.001

NT-proBNP (ng/L)

684.58 ± 145.96

49.37 ± 10.49

 < 0.001

NLR

5.73 ± 1.72

2.16 ± 0.43

 < 0.001

  1. VHD Valvular Heart Disease, NT-proBNP N-terminus pro-Brain Natriuretic Peptide, MPO Myeloperoxidase, NLR Neutrophil–Lymphocyte Ratio
Back to article page

Perioperative Medicine

ISSN: 2047-0525